ELOA3BP

Across TCGA pan-cancer cohorts, ELOA3BP RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated ELOA3BP data layer.

The strongest signal is observed in mesothelioma (MESO), where higher ELOA3BP RNA is associated with worse overall survival. In most high-consensus cancer types, elevated ELOA3BP expression acts as an unfavorable survival marker.

MESO, CHOL, and OV are the cancer types where ELOA3BP RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	III,IV	0.077	0.580	<.001	126	view →
CHOL	OS	Tertile	All	0.024	0.675	<.001	63	view →
OV	OS	Tertile	IV	0.056	0.772	<.001	54	view →
SKCM	DFS	Tertile	II,III,IV	0.248	0.693	.001	51	view →
PRAD	OS	Tertile	All	0.080	0.990	<.001	36	view →
PCPG	OS	Tertile	All	0.078	0.849	<.001	36	view →
SARC	OS	Tertile	All	0.133	0.860	<.001	18	view →
UCEC	DFS	Tertile	All	0.352	0.651	.011	18	view →
BLCA	DFS	Tertile	All	0.127	0.594	.020	18	view →
LGG	OS	Tertile	All	0.187	0.526	.036	6	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

ELOA3BP–MESO (OS)

Open the MESO breakdown →